DO analysis showed that 48 potential targets of HS were enriched in CRC, including PTGS2, DPP4, MAPK14, GSK3B, ACHE, CCND1, TNF, BAX, BCL2, CASP3, and CASP8 (Figure S1B). This evidence concerns the gene ACHE and colorectal carcinoma.